More postmenopausal women who took denosumab as well as daily doses of calcium and vitamin D gained at least 3% bone density at the hip and lumbar spine compared with those who got Fosamax and the supplements, U.S. scientists reported. Findings of the study, which involved nearly 1,200 women whose average age was 64, indicate that "denosumab is an effective agent," the lead researcher said.

Related Summaries